Merifund Capital Management Publishes Analysis of Unitree’s Shanghai IPO

New York, USA, August 27th, 2026, FinanceWire

Merifund Capital Management Pte. Ltd. has published an analysis of Unitree Robotics’ Shanghai debut, examining the valuation and commercial outlook for China’s humanoid robotics sector.

Shares in Unitree Robotics closed 460% above the offer price following their Shanghai debut this week. The listing raised approximately $915 million, while Chinese manufacturers accounted for about 97% of global humanoid robot shipments over the past six months, with Unitree representing roughly 31%.

The stock opens at $165, a 629% premium to the offer price of $22.6, then retreats through the session to settle at $126.8. That first-day gain sits well above the 279% average opening-day return across recent Chinese listings and follows the 466% debut of memory chipmaker CXMT the previous month. China’s benchmark equity index falls 3% on the same session, which underlines how far the listing runs counter to broader market conditions.

The opening surge lifts market capitalisation to roughly $66.7 billion before trading settles near $51.3 billion on the closing price, which leaves the company on a trailing price-to-earnings multiple approaching 1,190. Pre-listing guidance had targeted a valuation nearer $9.2 billion, a figure the market now treats as conservative for a manufacturer with gross margins around 60% that shipped some 5,500 humanoid units over the past year. Retail investors oversubscribe the current offering by more than 8,000 times.

Domestic manufacturers command more than 97% of global humanoid shipments across the same six months, and total volumes reach roughly 19,100 units, more than triple the level of a year earlier. Industrial and commercial applications now account for more than 70% of shipments against roughly 50% a year earlier, a shift that marks the debut as a moment when “capital has arrived well ahead of the commercial proof”, according to Anthony Saunders, who serves as Director of Private Equity at Merifund Capital Management. Independent forecasts place full-year volumes near 60,000 units, though the same work treats regulatory uncertainty and geopolitical risk as capable of reshaping the next phase of growth.

Beijing treats the sector as central to its pursuit of advanced technology leadership. A humanoid robot action plan from the Ministry of Industry and Information Technology and five other ministries sets a national deployment target of 100,000 units by the close of next year, and state support committed to the sector to date exceeds $19.1 billion in grants, loans, tax credits and venture capital. Tencent, Alibaba and the artificial intelligence group DeepSeek all hold positions, and the latter commits approximately $21.2 million under a three-year lock-up.

Competition already sits in very few hands, and two manufacturers take roughly 75% of world shipments over the past six months. Unitree ships 5,900 units across that period for 31% of global share, while Shanghai-based Agibot leads on 8,400 units and 44%. A ban introduced last month by the US Federal Communications Commission on imports of new foreign-made humanoid and quadruped robots removes Chinese manufacturers from the American market, where Unitree drew 13% of revenue last year, though previously authorised models remain exempt and small-batch research imports continue.

Technical constraints present the more durable obstacle to the commercial case now embedded in the share price. The company founder concedes that the absence of a mature, unified end-to-end artificial intelligence system remains the central challenge, and the prospectus acknowledges that robotic hands lack the precision and durability for large-scale adoption. Saunders describes the distance between laboratory capability and industrial deployment as “the single variable that decides whether these multiples survive”, and he sets that against the near three-quarters of humanoid revenue drawn from research and education in the prior year’s first nine months.

Bankers price the offering at roughly 219 times prior-year earnings and about 36 times sales, close to six times the general equipment manufacturing average. The closing price implies near 1,190 times reported earnings, set against net profit growth of 674% over the previous financial year, while Hong Kong-listed UBTech carries a market capitalisation of approximately $7.2 billion despite a net loss near $105 million over the past year. A free float of 7.44% of equity allows modest capital to anchor a substantial valuation, much as CXMT’s 6.73% float did on its debut the previous month. Merifund Capital Management continues to monitor advanced robotics, and Saunders sets the central test plainly when he observes that “fewer than one sale in ten reflects genuine industrial deployment today”.

About Merifund Capital Management

Merifund Capital Management Pte. Ltd. (UEN: 201024554E) was founded in 2010 and operates from Singapore as a leading hedge-fund manager, with expertise spanning traditional long-only asset and portfolio management, long/short equity, global macro, event-driven and systematic strategies. Derivatives are deployed selectively to capture market opportunity, always with capital preservation, liquidity and disciplined risk control at the centre of the approach. ESG factors form part of the firm’s adherence to demanding international sustainability standards. Its client base covers accredited investors, family offices, foundations and endowments, and now extends towards retail investors. Further analysis is published at https://merifund.com/insights, and media enquiries may be directed to Tao Yang at media@merifund.com or via https://merifund.com.

Contact